These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36799196)

  • 1. Precision Delivery of Dual Immune Inhibitors Loaded Nanomodulator to Reverse Immune Suppression for Combinational Photothermal-Immunotherapy.
    Tian Y; Younis MR; Zhao Y; Guo K; Wu J; Zhang L; Huang P; Wang Z
    Small; 2023 May; 19(21):e2206441. PubMed ID: 36799196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversing Immune Suppression and Potentiating Photothermal Immunotherapy via Bispecific Immune Checkpoint Inhibitor Loaded Hollow Polydopamine Nanospheres.
    Guo K; Chen D; Ren S; Younis MR; Teng Z; Zhang L; Wang Z; Tian Y
    ACS Appl Mater Interfaces; 2023 Mar; ():. PubMed ID: 36881613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A self-assembly active nanomodulator based on berberine for photothermal immunotherapy of breast cancer via dual regulation of immune suppression.
    Sun J; Ye T; Chen X; Li B; Wei Y; Zheng H; Piao JG; Li F
    Int J Pharm; 2024 Mar; 653():123898. PubMed ID: 38346604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JQ1-Loaded Polydopamine Nanoplatform Inhibits c-MYC/Programmed Cell Death Ligand 1 to Enhance Photothermal Therapy for Triple-Negative Breast Cancer.
    Tian Y; Wang X; Zhao S; Liao X; Younis MR; Wang S; Zhang C; Lu G
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46626-46636. PubMed ID: 31751121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision USPIO-PEG-SLe
    Li T; Guo L; Li J; Mu X; Liu L; Song S; Luo N; Zhang Q; Zheng B; Jin G
    Int J Nanomedicine; 2024; 19():1249-1272. PubMed ID: 38348177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
    Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
    Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-small Janus nanoparticle-induced activation of ferroptosis for synergistic tumor immunotherapy.
    Wang J; Wang Z; Li L; Wang M; Chang J; Gao M; Wang D; Li C
    Acta Biomater; 2024 Jun; 181():362-374. PubMed ID: 38663684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-thin layered double hydroxide-mediated photothermal therapy combine with asynchronous blockade of PD-L1 and NR2F6 inhibit hepatocellular carcinoma.
    Lu YF; Zhou JP; Zhou QM; Yang XY; Wang XJ; Yu JN; Zhang JG; Du YZ; Yu RS
    J Nanobiotechnology; 2022 Jul; 20(1):351. PubMed ID: 35907841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapy.
    Ge Y; Zhang J; Jin K; Ye Z; Wang W; Zhou Z; Ye J
    Acta Biomater; 2023 Sep; 167():551-563. PubMed ID: 37302731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin-ferrum nanoparticles enhance photothermal therapy by modulating the tumor immunosuppressive microenvironment.
    Li L; Zhang M; Liu T; Li J; Sun S; Chen J; Liu Z; Zhang Z; Zhang L
    Acta Biomater; 2022 Dec; 154():454-466. PubMed ID: 36243377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoscale Reduced Graphene Oxide-Mediated Photothermal Therapy Together with IDO Inhibition and PD-L1 Blockade Synergistically Promote Antitumor Immunity.
    Yan M; Liu Y; Zhu X; Wang X; Liu L; Sun H; Wang C; Kong D; Ma G
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):1876-1885. PubMed ID: 30582788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triune Nanomodulator Enables Exhausted Cytotoxic T Lymphocyte Rejuvenation for Cancer Epigenetic Immunotherapy.
    Li J; Zhao Q; Zhang N; Wu L; Wang Q; Li J; Pan Q; Pu Y; Luo K; Gu Z; He B
    ACS Nano; 2024 May; 18(20):13226-13240. PubMed ID: 38712706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy.
    Yang Q; Peng J; Shi K; Xiao Y; Liu Q; Han R; Wei X; Qian Z
    J Control Release; 2019 Aug; 308():29-43. PubMed ID: 31252039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
    Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
    Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allomelanin-based biomimetic nanotherapeutics for orthotopic glioblastoma targeted photothermal immunotherapy.
    Sun M; Li Y; Zhang W; Gu X; Wen R; Zhang K; Mao J; Huang C; Zhang X; Nie M; Zhang Z; Qi C; Cai K; Liu G
    Acta Biomater; 2023 Aug; 166():552-566. PubMed ID: 37236575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer.
    Chen Q; Zhang L; Li L; Tan M; Liu W; Liu S; Xie Z; Zhang W; Wang Z; Cao Y; Shang T; Ran H
    J Nanobiotechnology; 2021 Dec; 19(1):449. PubMed ID: 34952587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comprehensive Strategy Based on High Clinical Translational Nanosystem for Programmable Immunotherapy of Triple Negative Breast Cancer.
    Meng M; Wu J; Feng Y; Lin L; Chen J; Pang X; Li Y; Hao K; Tian H; Chen X
    Adv Mater; 2024 Jul; 36(27):e2314309. PubMed ID: 38520284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSH/pH dual response drug delivery system for photothermal enhanced gene-immunotherapy.
    Ma T; Li W; Ye J; Huang C; Li Y; Qiu H; Yin S
    Nanoscale; 2023 Nov; 15(42):16947-16958. PubMed ID: 37779508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size-optimized nuclear-targeting phototherapy enhances the type I interferon response for "cold" tumor immunotherapy.
    Zhang X; Yi C; Zhang L; Zhu X; He Y; Lu H; Li Y; Tang Y; Zhao W; Chen G; Wang C; Huang S; Ouyang G; Yu D
    Acta Biomater; 2023 Mar; 159():338-352. PubMed ID: 36669551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.